Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-04

Clinical Trial Update: New Onset Type 1 Diabetes: Role of Exenatide [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring the role of exenatide in new-onset Type 1 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Type 1 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2021-08-04